On World AIDS Day, December 1, we honor the advocates that transformed HIV/AIDS from a death sentence to a chronic disease. These activists bequeathed a golden age of global health—a boom in money and programs that is sustained today, evidenced by the recent reauthorization of PEPFAR. But as UNAIDS recognized last year, we still have miles to go despite this extraordinary mobilization. Even today, 40 percent of people in need still lack lifesaving antiretroviral treatment.
CGD Policy Blogs
CGD experts explain how the BRICS—home to 40 percent of all cases last year—could provide much-needed leadership on the global TB agenda.
In July, United States Global AIDS Coordinator Deborah Birx made a striking commitment: under her leadership, the President’s Emergency Plan for AIDS Relief (PEPFAR) would direct at least 40 percent of its funding to host country governments or organizations by the end of 2019—rising to 70 percent by the end of 2020. The bottom line: PEPFAR’s local targets are commendable in theory, but we suspect their application in practice will prove complicated. Below is our take on the related issues—and some recommendations for PEPFAR to forge the most effective path forward.
In recent years many global health institutions—particularly Gavi and the Global Fund—have adopted eligibility and transition frameworks for the countries they support. These frameworks lay out criteria under which countries will lose eligibility for their support, and, typically, a gradual timeframe to phase out external financing. The question of how these transitions will play out in practice—and whether global health progress will be put at risk through premature or poorly planned transitions—is a hot topic in global health.
We finally have some clarity on PEPFAR’s new “acceleration” strategy toward epidemic control: a lot more allocated to a few countries, and a lot less for others.
At CGD, we believe that the thoughtful application of economic theory and evidence can help build a better world. This conviction is clearly shared by Dr. Jean Tirole, Nobel laureate in economics and chairman of the Toulouse School of Economics (TSE).